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Background: The stomach is the most common site for gastrointestinal stromal tumors (GIST) develop-
ment. Surgical treatment consists of excision of the entire neoplastic mass, with sufﬁcient surgical
margins within healthy tissue. This can be achieved with different techniques ranging from wedge re-
sections, typical gastric resections, right up to total gastrectomy. There aren’t clear guidelines for the use
of minimally invasive approach.
Materials and methods: From January 2011 to April 2012, 5 patients with presumed preoperative diag-
nosis of GIST were treated by robotic surgery at the Unit of Surgery and Advanced Oncologic Therapies,
Forlì Hospital, Forlì, Italy. We report operative techniques, perioperative outcomes and follow-up.
Results: Lesions were localized at anterior wall of gastric antrum (N ¼ 2) and near pyloric area (N ¼ 3).
Mean tumor size was 5 cm (range 4e7 cm). Surgical procedures were 5 distal gastrectomy. None
intervention was converted to open surgery and there weren’t major intraoperative complications.
Median operative time was 240 min (range 210e300 min) and mean intraoperative blood loss was 96 ml
(80e120 ml). All lesions had microscopically negative resection margins. Median follow-up was 13.5
months (range 12e15 months) with a disease-free survival rate of 100%.
Conclusions: Surgical robotic approach for large GISTs is feasibility and new evidences are needed to
clarify the effective role of different surgical strategies.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Gastrointestinal stromal tumors (GIST) are the most common
intestinal mesenchymal tumors with an incidence of 20 cases per
million.1
Surgical treatment allows neoplastic mass and gastric wall
excision up to free margin. This can be achieved depending on
tumor dimension and localization, through different techniques
such as wedge resection for small GISTs, gastric resection, total
gastrectomy in case of large dimension and localization near
cardia.2
Laparoscopic interventions are limited by dimension and
localization of the tumor and by the necessity to avoid intra-




ciates Ltd. Published by Elsevier LtRecent studies on primitive gastric GISTs4e7 seem encouraging
with respect to cautions expressed by Consensus Conference that
had limited laparoscopic approach only to GIST < 2 cm (National
Comprehensive Cancer Network - NCCN),8 or that had excluded this
approach (European Society for Medical Oncology - ESMO - Con-
sensus Conference, 2004)9 because intraoperative lack of sense of
touch may facilitate neoplastic tissue fragmentation.
Robotic surgery has started to have an important role in
abdominal surgery and different studies on robot use for gastric
diseases evidenced efﬁcacy and feasibility of this mini-invasive
approach.10e12
The aim of this study is to report our preliminary experience in
robotic treatment for gastrointestinal stromal tumors of the
stomach and evaluate surgical and oncologic short-term outcomes.2. Materials and methods
From January 2011 to April 2012, 5 patients with presumed preoperative diag-
nosis of GIST that was conﬁrmed by immunohistochemical study of the lesion, were
treated by robotic surgery (Da Vinci; Intuitive Surgical, Inc., Sunnyvale, CA) and
underwent follow up at the Unit of Surgery and Advanced Oncologic Therapies, Forlì
Hospital, Forlì, Italy.d. All rights reserved.
Fig. 1. Section of gastro-colic ligament.
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executed by esophagogastroduodenoscopy and computed tomography (CT), while
endoscopic ultrasonography (EUS) and core-needle biopsy were performed only
when clinically indicated.
Lesions were post-operatively diagnosed as GIST using immunohistochemistry
that showed CD117 (KIT) positive cells.
Patients’ characteristics and clinical presentation are reported in Table 1. Oper-
ative time was calculated as the time between skin incision and port-site closure.
Measured perioperative parameters included estimated blood loss, intraoperative
ﬁndings, morbidity, and length of hospitalization. In addition, tumor histopathologic
characteristics including size, location, tumor marker status and mitotic activity
were analyzed. All operations were performed by experienced laparoscopic and
robotic surgeons.
According to Fletcher criteria,13 tumors of less than 2 cm in diameter and with
a mitotic count (MC) of less than 5 of 50 high-power ﬁelds (HPFs) were classiﬁed as
very low risk tumors. Low risk was identiﬁed for size from 2 to 5 cm and MC less
than 5 of 50 HPFs, intermediate risk for tumor size less than 5 cm and 6e10MC of 50
HPFs or when the tumor size was 5e10 cm and the MC less than 5 of 50 HPFs, high
risk was determined when tumor size was greater than 10 cm or the MCwas greater
than 10 of 50 HPFs or the tumor size was greater than 5 cm and the MC was greater
than 5 of 50 HPFs.
Lesions localized mostly on the outer wall of the stomach have been deﬁned as
having an exophytic growth pattern, those predominantly located on the inner wall
of the stomach were instead deﬁned as endophytic growth pattern.14
The present series shows a surgical approach for tumors of the antrum and pre-
piloric area with distal gastrectomy performed because more limited approaches
were not feasible.
All patients who underwent robotic treatment of gastric GIST were prospec-
tively followed-up with routine visits, ﬁrstly one month after the operation, then
every 6 months with computed tomography and gastroscopy in order to evaluate
recurrence of disease.
2.1. Operative techniques
The “Da Vinci” Surgical System (Intuitive Surgical Inc, Sunnyvale, CA) is a tele-
robotic system controlled from a surgeon at remote console, while surgical team
is close to operating table and follows the procedure through a service screen. In
order to facilitate team coordination, we located operative console in a corner of the
operating room.
Patient was supine with arms along the body. After pneumoperitoneum in-
duction through peri-umbilical Veress needle, 12 mm Trocar for optics and other
three 8 mm robotic Trocars were positioned.
After insertion of the ports, the patient was placed in a reverse Trendelenburg’s
position.
At the beginning of every intervention abdominal, conventional laparoscopic
exploration was performed in order to rule out peritoneal seeding or hepatic
metastasis.
During robot setup, console was connected to robot and automatic checkup
veriﬁed correct functioning of robotic arms, then optic setup was done. At this point
the correct position of robotic cart is fundamental so that robotic arms do not to
interfere among themselves.
During the procedure we add 12 mm extra-port for accessory surgical in-
struments controlled by the assistant surgeon. In fact, a second experienced surgeon
was at the bedside to exchange the robotic instruments, retract for exposure and
assist with the procedure. Lesions were never directly manipulated with robotic
instruments in order to avoid tumor rupture.
Intraoperative endoscopy was performed in all cases in order to facilitate
localization of the lesion, evaluate appropriate surgical technique and assist in the
identiﬁcation of correct resection margins.
In the ﬁve cases reported, because of the intramural localization in the pre-
pyloric area and GIST’s dimensions, larger gastric resectionwas performed following
a procedure that is described below.
Tumors larger than 3 cm in this location carry the risk of gastric outlet stenosis
after wedge resection. We considered that in this case a limited approach was not
feasible and distal gastrectomywas the best alternative. Therefore, section of gastro-
colic ligament was performed (Fig. 1) with access to omental bursa (Fig. 2) after
a precise evaluation of tumor location, followed by isolation and section withTable 1
Characteristics of patients enrolled in the present study.
Patients Gender Age Symptom/sign
1 M 69 No symptoms
2 F 43 No symptoms
3 M 71 No symptoms
4 F 59 Abdominal discomfort and dyspepsia
5 F 76 Bleeding with acute anemiaemolock clips of right gastric artery and right gastroepiploic vessels (Fig. 3), duo-
denal isolation and section distally to lesion with mechanical stapler (Fig. 4). Gastric
resection was executed in the distal 2/3 of the stomach (Fig. 5). Finally surgical
specimen was removed through endocatch.
A side-to-side one-row gastro-jejunal anastomosis is performed with running
PDS 2-0 suture.(Figs. 6 and 7).
3. Results
This study reports characteristics of 5 patients with gastric GIST
who underwent robotic surgical resection. There were 2 men and 3
women with mean age of 63.6 years (range 43e76 years). Three
patients were asymptomatic and lesions were discovered after
esophagogastroduodenoscopy, 1 patients referred abdominal dis-
comfort and dyspepsia, 1 patient rectal bleedingwith acute anemia.
The endoscopic investigations including EUS showed typical
characteristics of GIST in all cases and their patterns of growth, the
biopsy was performed preoperatively in three cases to increase the
diagnostic accuracy but has not been performed in two patients at
high risk of bleeding.
None patient underwent neoadjuvant therapy with tyrosine
kinase inhibitor, Imatinib.
Lesions were localized at anterior wall of gastric antrum (N ¼ 2)
and near pyloric area (N¼ 3). One GIST presented exophytic pattern
of grown. Mean tumor size was 5 cm (range 4e7 cm). Surgical
procedures were 5 distal gastrectomy.
None intervention was converted to open surgery, nor there
were tumor ruptures or spillage, nor major intraoperative compli-
cations and all lesions had microscopically negative resection
margins that conﬁrmed complete radicality of surgical intervention
(R0). Estimated intraoperative bleeding has been negligible (mean
of 96 ml, range 80e120 ml), and no blood transfusions were
necessary in the perioperative period.
Histopatological analysis according to Fletcher criteria13 classi-
ﬁed 2 GISTs as low risk and 3 GISTs as intermediate risk.Tumor location Growth pattern Size (cm) Fletcher criteria
Antrum Endophytic 5 Low risk
Antrum Endophytic 4 Intermediate risk
Prepyloric Endophytic 4 Low risk
Prepyloric Endophytic 7 Intermediate risk
Prepyloric Exophytic 5 Intermediate risk
Fig. 2. Access to omental bursa. Fig. 4. Duodenal section with mechanical stapler.
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Therewas no postoperativemorbidity (such as bleeding or leaks)
nor mortality and none patient experienced anastomotic stricture.
Mean hospital stay (from surgical intervention to discharge)was 4.2
days (range 3e5 days). Median follow-up was 13.5 months (range
12e15 months) with a disease-free survival rate of 100%.
4. Discussion
Stomach is themost common site of GIST localization (65%) with
an intraluminal or exophytic pattern of growth toward the lumen
or the peritoneum with different biological behavior for aggres-
siveness, recurrence and tendency to metastasize.15
Lymph node involvement is very rare and lymphectomy is not
necessary.16 Recurrence is instead more frequent and is mostly
peritoneal where tumor surface is directly in contact with coelomic
cavity rather than in the thickness of visceral wall at the resection
margin.17
Tumor pseudo-capsule displaces surrounding structures rather
than inﬁltrate them and often presents clivage plane, but it is easily
friable with peritoneal colonization that can be spontaneous or
caused by surgical manipulation.18
Studies that investigated the relation between histologic posi-
tivity of resection margin and frequency of recurrence did not giveFig. 3. Section with emolock clips of right gastroepiploic vessels.univocal results, demonstrating absence of correlation in some
cases,19 while in others there was a negative effect on survival20,21
but incomplete macroscopic removal of neoplastic tissue, as for
example during palliative intervention for obstruction or bleeding
that determined reduction in survival.22
Surgical resection of localized gastric GISTs in absence of distant
metastasis is the treatment of choice.23 Besides, these tumors sel-
dom develop loco-regional recurrence, which supports the practice
of limited gastric resection with a 1- to 2-cm margin necessary for
an adequate radicality24 and authors agree that surgical purpose
has to be complete resection with negative margins without rou-
tine lymphadenectomy.25 For this reason wedge resection is indi-
cated for the majority of gastric GISTs.26,27 Anyway tumor size and
location may dictate a more extensive surgery, including partial or
total gastrectomy, as in our enrolled patients.2 Laparoscopy is
indicated as a safe and valid method from an oncological point of
view,28e30 however current guidelines8 suggest that mininvasive
approach should be reserved to tumor <2 cm. This recom-
mendation derives from the impossibility of having a direct
manipulation of lesion with the risk of rupture and dissemination
that would represent a catastrophic consequence in terms of
recurrence and survival of the patient.23,31 In our series, mean tu-
mor size was>2 cm (5 cm) but none patient underwent lacerationsFig. 5. Gastric resection in the distal 2/3 of the stomach.
Fig. 6. View of the side-to-side gastro-jejunal anastomosis.
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experience and adequate used instruments. In fact, different stud-
ies report feasibility and safety of mininvasive techniques for lager
GISTs, both laparoscopy6,32,33 and robotics.34
In our experience, the correct identiﬁcation of tumor local-
ization was considered more important than tumor dimension in
order to decide which would be the more adequate surgical
approach and type of resection to be performed.
Laparoscopic surgery is now widely recognized and used as
a mini invasive approach to many procedures, because it offers
a variety of beneﬁts when compared to open surgery.35 These
include less pain, faster postoperative recovery times, reduced
morbidity and fewer complications.36 Laparoscopic gastrectomy
has been adopted in many centers, but has proved a complex
procedure that introduces obstacles associated with the limited
movement of instruments and the ampliﬁcation of hand tremors
and two-dimensional vision. Robotic gastric surgery was intro-
duced to overcome these problems.37 Themajority of studies on the
use of this technique are case series that have been limited through
the small sample size and the insufﬁcient data on the oncological
outcomes that nevertheless highlight the practicality of using the
robotic procedure.38e40 There are however no studies to assess the
advantages when compared with classic laparoscopic procedures.Fig. 7. Robotic suture of the aperture.To date there are no RCTs and only three comparative studies41e43
have been conducted on robotic oncological gastric surgery.
The published ﬁndings do not demonstrate any differences be-
tween the two treatment groups with regard to perioperative
complications, conversion rates and postoperative stay. The three
studies do however highlight that intraoperative blood loss was
signiﬁcantly less in the robotic group compared to the laparoscopic,
a difference that is attributable to a clearer view of the operating
area and the magniﬁcation of the image. However, the studies that
have been analyzed are limited in as much as they do not provide
data concerning long-term follow-up and this makes it necessary to
produce new evidence and randomized trials.
Actually it’s verydifﬁcult to try to determinewhether there is any
difference between robotic and laparoscopic gastrectomy for ma-
lignant disease. The fact that only three trials are suitable for com-
parative considerations shows the lack of data generally available.
The bibliographic research on surgical treatment of gastric GIST
showed that several authors described laparoscopy,6,28,29,44e47
while only one study reported cases treated with robotic system
with adequate description of used technique.34
The current study is a case series of 5 patients who underwent
robotic gastric resection.
Our personal experience evidences usefulness of robotic system
to improve dexterity of a surgeon during complex mini-invasive
procedures and to facilitate traditional laparoscopic approach.
Mini-invasive gastric surgery is considered not doable and risky
for large and pre-pyloric GISTs because of the anatomic positioning,
fragility of the tumor capsule and difﬁculties to perform laparo-
scopic sutures.8
We have shown that tridimensional image magniﬁcation and
precise robotic arm movements with tremor ﬁltering could help
gastric resection for GISTs without intra-abdominal dissemination
and margin-free specimen.
The unfavorable factor reported in several studies48 is the
increased operative time than laparoscopic approach caused by the
placed and doked of the system’s patient cart and the robot setup.
However, in our series the mean operative time was 240 min,
favorably if compared with data reported in literature for laparo-
scopic resection.49e51
Also, in our series we have observed no signiﬁcant intra-
operative blood loss (mean of 96 ml) and no need for transfusion,
there were not major intraoperative complications or perioperative
morbidity.
The advantages associated with the use of a robotic minimally
invasive technique mainly concerned a hospital stay particularly
short and regular: in ﬁrst postoperative day all the patients started
oral liquid intake and median referred Visual Analog Scale (VAS)
score for pain52 was 3. The mean hospital stay was 4.2 days and
physical examination at discharge showed not painful, palpable
abdomen, normal bowel functioning and hematological laboratory
values. No complications were reported in all patients both peri-
operatively and at follow-up, a quick return to daily activities was
demonstrated by the Short Form-12 (SF-12) assessment scale.53 In
particular this questionnaire was submitted one-month to surgical
intervention. All patients answer not limitations in moderate ac-
tivities or problems with work and other regular daily activities as
a result of their physical health.
Furthermore, the goal of oncological radicality was reachedwith
tumor-free margins (R0) and no recurrence in the short-term
observation period.
Even if comparative studies are necessary to demonstrate real
advantages of robotic approach with respect to classic laparoscopy,
Da Vinci Surgical System allows large tridimensional ﬁeld of view,
a steady traction, tremor suppression, ﬂexibility of the instruments
and offers improved dexterity with an internal articulated
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seven degrees of freedom and therefore execution of precise and
safe dissection of tissue and sutures.38
We think that minimally invasive surgery for large gastric GIST
appear now more viable and safe in selected patients through the
increasing experience of dedicated laparoscopy surgeons with
development of the concept of “team approach” and technological
improvements.54 New guidelines and discussions we seem
necessary.
Even if this study was not speciﬁcally realized to compare dif-
ferent surgical approaches, nevertheless it demonstrates the fea-
sibility and efﬁcacy of surgical robotic treatment. We believe
further evidences are needed as well as comparative studies in
order to clarify the effective role of different surgical strategies in
the treatment of gastric GIST.5. Conclusions
The NCCN Clinical Practice Guidelines for Optimal Management
of Patients with GIST8 suggests that laparoscopic techniques should
be limited to tumors less than 2 cm, but some authors have
reported successful and safe removal of larger GISTs.6,28,33 So if
laparoscopy appears very appealing, the main problem using the
classical laparoscopic approach is inadequate resection margins or
tumor spillage that can results in catastrophic consequences with
disease progression, recurrence, and poor survival. Advantages of
“Da Vinci” Surgical system are the dexterity of the Endowrist, that
could extend the feasibility of a minimally invasive approach to
patients requiring advanced suturing, precise tissue dissection and
tridimensional visualization of the operative ﬁeld. We suggest that
both these characteristics allow overcoming lack of tactile feed-
back that is considered fundamental for GIST treatment.
However, the literature contains no evidences on the correct
management of large GISTs and in particular on the validity and role
of the minimally invasive surgery.
We studied the feasibility of the robotic procedure to provide
a mean for the design of future studies that could evaluate beneﬁts
of this approach versus open and laparoscopic surgery.
The present series demonstrates that robotic resection for gas-
tric GIST can be safely adopted not only for its advantages of min-
imally invasive surgical technique but also because it was
associated with a favorable perioperative outcome without com-
promising oncologic safety and with encouraging results in terms
of earlier return of bowel function, earlier resumption of diet,
decreased duration of the use of analgesia and shorter post-
operative hospitalization.
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